Melissa Fergus

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

Rebecca M. Baker, Phuong Thi Tuyet Nguyen, Carol L. Eyler, 2021, The Lancet Infectious Diseases.

Association between unmet medication needs after hospital discharge and readmission or death among acute respiratory failure survivors: the addressing post-intensive care syndrome (APICS-01) multicenter prospective cohort study

Jorie M. Butler, Samuel M. Brown, D. Needham, 2022, Critical Care.

Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial

Michael L. Nelson, Brad T. Sherman, I. Douglas, 2023, The Lancet Respiratory Medicine.

Prescription of potentially inappropriate medications after an intensive care unit stay for acute respiratory failure.

C. Sevin, Maria C. Karamourtopoulos, M. Mir-Kasimov, 2024, Australian critical care : official journal of the Confederation of Australian Critical Care Nurses.